Mobile app monitoring may reduce serious complications after surgery, new study finds - Medical Xpress
Mobile app-based monitoring may help address the vulnerable days and weeks after surgery when recovery shifts from the hospital to home with little direct supervision. Patients using mobile apps had a lower risk of serious complications, emergency room visits and readmissions after surgery, but the benefits depended on physician or other clinician involvement, rather than the technology alone, according to research presented at the Anesthesiology 2026 annual meeting.
"Just using an app may not make recovery safer," said Mouad Elganga, B. S., lead author of the study and a medical student at the Temerty Faculty of Medicine, University of Toronto.
This article is an excerpt. To read the full content, visit the original source. Medical Xpress
Related articles
Kefah Mokbel: Can Whole-Genome Sequencing-Based ctDNA Monitoring Help Personalize Adjuvant Treatment? - Oncodaily
“Beyond Detecting Cancer Recurrence: Can Whole-Genome Sequencing-Based ctDNA Monitoring Help Personalize Adjuvant Treatment? An exciting new study published in The Oncologist highlights the clinical potential of Signatera Genome, a whole-genome sequencing (WGS)-based, tumor-informed circulating tumor DNA (ctDNA) assay, not only for detecting molecular residual disease (MRD), but also for potentially informing adjuvant treatment decisions.
WOAH Warns of Sharp Rise in Vector-Borne Disease Reports - Vet Candy
New global surveillance data reveal dramatic increases in reported bluetongue and West Nile fever events, raising concerns about climate change, expanding disease territories, and the future of animal health. The world's disease map is changing, and veterinarians are being urged to pay attention. From biting midges carrying bluetongue virus across Europe to mosquitoes spreading West Nile fever, vector-borne diseases are emerging in new regions, creating growing challenges for animal health professionals, livestock producers, and public health officials. The World Organisation for Animal Health (WOAH) issued a warning on October 9, 2026, calling for stronger disease surveillance, earlier detection, and better international cooperation as reports of several vector-borne diseases continue to climb. An analysis of information submitted through the World Animal Health Information System (WAHIS) reveals a particularly striking increase in reported exceptional epidemiological events since 2023. The findings suggest that shifting environmental conditions, changing vector populations, and animal movements are reshaping where certain infectious diseases can spread.
Designing Clinical Trials for Real-World Access - Targeted Oncology
Rethink trial design with decentralized, community-based models to cut barriers, let patients enroll closer to home, and preserve high-quality safety data. Making clinical trials more accessible requires rethinking how studies are designed, supported, and conducted, particularly for patients receiving care in community settings. In an interview with Targeted Oncology, Krish Patel, MD, executive director of hematologic cancer research at Sarah Cannon Research Institute, discusses the role of trial sponsors, research organizations, community oncology sites, and regulatory agencies in reducing barriers to participation. Patel emphasizes that while community oncology sites may have varying capabilities, they care for a large proportion of patients who could benefit from clinical trial participation. He argues that stakeholders should reassess which traditional trial requirements are truly necessary to determine whether a therapy is safe and effective and which may create unnecessary barriers for patients and sites. One potential solution is greater use of decentralized trial models.
0 comments
No comments yet. Be the first to share your thoughts!